Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Enterprise Value for 3 consecutive years, with $701156.2 the latest figure, recorded in Q4 2025.

• Quarterly Enterprise Value fell 89.62% year-over-year to $701156.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $701156.2 (down 89.62% YoY) and the FY2025 annual result came in at $815330.0, down 87.53% from the prior year.
• Enterprise Value fell to $701156.2 in Q4 2025 per ZYBT's latest filing, from $2.7 million in the prior quarter.
• Over the last five years, Enterprise Value for ZYBT reached as high as $6.8 million in Q4 2024 and fell as low as $701156.2 in Q4 2025.
• A 3-year average of $3.5 million and a median of $3.2 million in 2023 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2024 — Enterprise Value soared 79.39% — and 2025, when it slumped 89.62%.
• Year by year, Enterprise Value stood at $3.8 million in 2023, then surged by 79.39% to $6.8 million in 2024, then sank by 89.62% to $701156.2 in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered $701156.2, $2.7 million, and $6.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.